New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Amgen Inc. (AMGN) vs Sanofi (SNY)
- Amgen Inc. AMGN 439.53 +0.17%
- Sanofi SNY 46.58 +1.13%
Amgen Inc. and Sanofi are both Drug Manufacturers General companies. Amgen Inc. is the larger, with a market value of $237.4B against $111.3B — 2.1× the size. Sanofi trades at the lower P/E: 22.8× against 25.2×. Sanofi grew revenue faster over the last twelve months: 26.3% against 8.15%. Amgen Inc. has the higher net margin (24.1% vs 8.27%) and the higher return on invested capital (14.3% vs 7.05%). Both pay a dividend; Sanofi yields more (5.25% vs 2.84%). Across the 23 metrics below, Sanofi leads on 14 and Amgen Inc. on 9.
Valuation
Profitability
| Metric | AMGN | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 70.90% | 73.44% | 73.01% |
| Operating margin | 32.41% | 18.73% | 18.34% |
| Net margin | 24.14% | 8.27% | 7.31% |
| Free cash flow margin | 24.63% | 40.26% | 18.56% |
| Return on equity | 78.35% | 0.00% | 20.02% |
| Return on assets | 10.09% | 3.24% | 2.28% |
| Return on invested capital | 14.29% | 7.05% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack